Olink Holding AB (publ)
OLK
Ранг среди акций
#4801
Olink Holding AB (publ) offers a comprehensive suite of products and services... Olink Holding AB (publ) offers a comprehensive suite of products and services tailored for life science research institutions, including academic bodies, government entities, biopharmaceutical companies, and biotechnology firms. The company's product lines include Olink Explore, which is designed to aid research in critical areas such as cardiovascular and metabolic health, oncology, neurology, and inflammation. Additionally, it features the Olink Target product line and the Olink Focus product line, the latter providing bespoke solutions for clients who have already pinpointed specific proteins or protein signatures for their studies. Beyond these, Olink supplies the Signature Q100, a dedicated platform for qPCR (quantitative Polymerase Chain Reaction) readouts. Its service portfolio encompasses Olink Analysis, offering end-to-end support from study design and expert consultation to sample preparation, assay execution, and stringent quality control of data, complemented by bioinformatics services. For data management and analysis, Olink provides the normalized protein expression (NPX) Manager, a specialized software tool enabling users to import data, validate its quality, and normalize findings in preparation for statistical analysis. Furthermore, Olink Insight serves as a cloud-based platform for visualizing and statistically analyzing NPX data. Olink Holding AB (publ) markets and sells its offerings worldwide through its proprietary direct sales force, reaching customers across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Established in 2004 and based in Uppsala, Sweden, the company underwent a name change in January 2021 from its former identity, Knilo HoldCo AB, to its current designation. It operates as a subsidiary of Summa Equity Holding AB.
Цена акции
$26.08
Последняя синхронизация: 2024-07-09
Рыночная капитализация
$3.10B
Изменение (1 день)
0.31%
Изменение (1 год)
0.00%
Страна
SE
Торговля Olink Holding AB (publ) (OLK)
Категория
Healthcare
EPS для Olink Holding AB (publ) (OLK)
EPS по состоянию на March 2024 TTM: $-0.27
Согласно последним финансовым отчетам и цене акций Olink Holding AB (publ), текущий EPS компании (TTM) составляет $-0.27. В конце 2022 EPS компании составлял $-0.11, меньше, чем показателю 2021 года, равному $-0.39.
История EPS компании Olink Holding AB (publ) с 2019 по 2026
EPS на конец каждого года
| Год | EPS | Изменить |
|---|---|---|
| 2026 (TTM) | $-0.27 | 3.85% |
| 2023 | $-0.26 | 136.36% |
| 2022 | $-0.11 | -71.79% |
| 2021 | $-0.39 | 584.21% |
| 2020 | $-0.06 | -62.00% |
| 2019 | $-0.15 | 0.00% |
EPS для аналогичных компаний или конкурентов
| Компания | EPS | Разница в EPS | Страна |
|---|---|---|---|
| $18.62 | -6,996.30% |
US
|
|
| $5.65 | -2,192.59% |
US
|
|
| $-1.36 | 403.70% |
US
|
|
| - | - |
CN
|
|
| $5.09 | -1,985.19% |
US
|
